Abundance of <i>P</i>-glycoprotein and Breast Cancer Resistance Protein Measured by Targeted Proteomics in Human Epileptogenic Brain Tissue.

导出 OA

翻译打印收藏纠错

作者： Aniv Mann,Brukner ^[1] ; Sarah,Billington ^[2] ; Mony,Benifla ^[3] ; Tot Bui,Nguyen ^[2] ; Hadas,Han ^[1] ; Odeya,Bennett ^[4] ; Tal,Gilboa ^[5] ; Dana,Blatch ^[6] ; Yakov,Fellig ^[7] ; Olga,Volkov ^[6] ; Jashvant D,Unadkat ^[8] ; Dana,Ekstein ^[9] ; Sara,Eyal ^[2]

作者单位： Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Room 613, Ein Kerem, Jerusalem 91120, Israel. ^[1] Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington 98195, United States. ^[2] Children's Neurosurgery Department, Rambam Academic Hospital, Haifa 31999, Israel. ^[3] Department of Pediatrics, Shaare Zedek Medical Center, Jerusalem 91031, Israel. ^[4] Neuropediatric Unit, Pediatrics Division, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel. ^[5] The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel. ^[6] Department of Neurology, Agnes Ginges Center for Human Neurogenetics, Hadassah Medical Organization, Jerusalem 91120, Israel. ^[7] Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel. ^[8] Nuclear Medicine Institute, Sheba Medical Center, Tel Hashomer 52621, Israel. ^[9]

关键词 P-glycoprotein antiepileptic drugs antiseizure medications breast cancer resistance protein epilepsy targeted proteomics